Immune control of HIV-1 infection after therapy interruption: immediate versus deferred antiretroviral therapy

被引：0
|
作者：
Paola Paci
Rossella Carello
Massimo Bernaschi
Gianpiero D'Offizi
Filippo Castiglione
机构：
[1] National Research Council,Institute for Computing Applications "Mauro Picone"
[2] I.R.C.C.S.,National Institute for Infectious Diseases "Lazzaro Spallanzani"
[3] San Pietro Hospital,Research Center
[4] Fatebenefratelli,undefined
[5] AFaR,undefined
来源：
BMC Infectious Diseases | / 9卷
关键词：
Human Immunodeficiency Virus; Viral Rebound; Plasma Viremia; Public Health Expenditure; Nucleic Acid Sequence Base Amplification;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Immune activation in the course of HIV-1 infection: Causes, phenotypes and persistence under therapy
    Younas, M.
    Psomas, C.
    Reynes, J.
    Corbeau, P.
    HIV MEDICINE, 2016, 17 (02) : 89 - 105
  • [22] Inflammation, Immune Activation, and Antiretroviral Therapy in HIV
    Hileman, Corrilynn O.
    Funderburg, Nicholas T.
    CURRENT HIV/AIDS REPORTS, 2017, 14 (03) : 93 - 100
  • [23] Natural killer cells in HIV-1 infection and therapy
    Mikulak, Joanna
    Oriolo, Ferdinando
    Zaghi, Elisa
    Di Vito, Clara
    Mavilio, Domenico
    AIDS, 2017, 31 (17) : 2317 - 2330
  • [24] Markers associated with persisting low-level viraemia under antiretroviral therapy in HIV-1 infection
    Vancoillie, Leen
    Demecheleer, Els
    Callens, Steven
    Vogelaers, Dirk
    Vandekerckhove, Linos
    Mortier, Virginie
    Verhofstede, Chris
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2014, 69 (04) : 1098 - 1103
  • [25] The development of antiretroviral therapy and its impact on the HIV-1/AIDS pandemic
    Broder, Samuel
    ANTIVIRAL RESEARCH, 2010, 85 (01) : 1 - 18
  • [26] A mature macrophage is a principal HIV-1 cellular reservoir in humanized mice after treatment with long acting antiretroviral therapy
    Arainga, Mariluz
    Edagwa, Benson
    Mosley, R. Lee
    Poluektova, Larisa Y.
    Gorantla, Santhi
    Gendelman, Howard E.
    RETROVIROLOGY, 2017, 14
  • [27] Immune and Viral Correlates of "Secondary Viral Control" after Treatment Interruption in Chronically HIV-1 Infected Patients
    Van Gulck, Ellen
    Bracke, Lotte
    Heyndrickx, Leo
    Coppens, Sandra
    Atkinson, Derek
    Merlin, Celine
    Pasternak, Alexander
    Florence, Eric
    Vanham, Guido
    PLOS ONE, 2012, 7 (05):
  • [28] Different profiles of immune reconstitution in children and adults with HIV-infection after highly active antiretroviral therapy
    Salvador Resino
    Elena Seoane
    Alicia Pérez
    Ezequiel Ruiz-Mateos
    Manuel Leal
    Maria Á Muñoz-Fernández
    BMC Infectious Diseases, 6
  • [29] Healthy HIV-1-Infected Individuals on Highly Active Antiretroviral Therapy Harbor HIV-1 in Their Alveolar Macrophages
    Cribbs, Sushma K.
    Lennox, Jeffrey
    Caliendo, Angela M.
    Brown, Lou Ann
    Guidot, David M.
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2015, 31 (01) : 64 - 70
  • [30] A therapeutic HIV-1 vaccine enhances anti-HIV-1 immune responses in patients under highly active antiretroviral therapy
    Tung, Frank Y.
    Tung, Jack K.
    Pallikkuth, Suresh
    Pahwa, Savita
    Fischl, Margaret A.
    VACCINE, 2016, 34 (19) : 2225 - 2232
12345